Question 1

What are the potential benefits and risks of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Assess the Safety, Tolerability, and Effect on Disease Progression of BIIB105 in Participants With Amyotrophic Lateral Sclerosis (ALS) and Participants With the ALS Ataxin-2 (ATXN2) Genetic Mutation clinical trial (NCT04494256). Contact the study team or your healthcare provider for specific answers.

Question 2

How does BIIB105 compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Assess the Safety, Tolerability, and Effect on Disease Progression of BIIB105 in Participants With Amyotrophic Lateral Sclerosis (ALS) and Participants With the ALS Ataxin-2 (ATXN2) Genetic Mutation clinical trial (NCT04494256). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the participation involve in terms of visits and procedures?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Assess the Safety, Tolerability, and Effect on Disease Progression of BIIB105 in Participants With Amyotrophic Lateral Sclerosis (ALS) and Participants With the ALS Ataxin-2 (ATXN2) Genetic Mutation clinical trial (NCT04494256). Contact the study team or your healthcare provider for specific answers.

Question 4

How long will I need to be in the study, and what happens after?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Assess the Safety, Tolerability, and Effect on Disease Progression of BIIB105 in Participants With Amyotrophic Lateral Sclerosis (ALS) and Participants With the ALS Ataxin-2 (ATXN2) Genetic Mutation clinical trial (NCT04494256). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any side effects I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Assess the Safety, Tolerability, and Effect on Disease Progression of BIIB105 in Participants With Amyotrophic Lateral Sclerosis (ALS) and Participants With the ALS Ataxin-2 (ATXN2) Genetic Mutation clinical trial (NCT04494256). Contact the study team or your healthcare provider for specific answers.

Question 6

Can I continue my current medications while participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Assess the Safety, Tolerability, and Effect on Disease Progression of BIIB105 in Participants With Amyotrophic Lateral Sclerosis (ALS) and Participants With the ALS Ataxin-2 (ATXN2) Genetic Mutation clinical trial (NCT04494256). Contact the study team or your healthcare provider for specific answers.

What this study is about